1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Crizanlizumab, Voxelotor, and L‐glutamine for sickle cell disease: effectiveness and value. Institute for Clinical and Economic Review

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Hematology

          Comments

          Comment on this article